Long-term hepatic outcomes in survivors of stage 4S and 4 neuroblastoma in infancy

Pediatric Blood and Cancer

Volumn 58, Issue 2, 2012, Pages 283-288

  French, Amy E ^a   Irwin, Meredith S ^a   Navarro, Oscar M ^a   Greenberg, Mark ^a   Nathan, Paul C ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Infants; Liver; Neuroblastoma; Outcomes; Stage 4; Stage 4S

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; BILIRUBIN;

ABDOMINAL RADIOTHERAPY; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; INFANT; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER METASTASIS; LIVER SCINTISCANNING; MALE; NEUROBLASTOMA; NODULAR HYPERPLASIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 83455253784     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23077     Document Type: Article

References (35)

1. Gurney JG, Ross JA, Wall DA, et al. Infant cancer in the U.S.: Histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol 1997; 19: 428-432.
2. Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet 2007; 369: 2106-2120.
3. Gao RN, Levy IG, Woods WG, et al. Incidence and mortality of neuroblastoma in Canada compared with other childhood cancers. Cancer Causes Control 1997; 8: 745-754.
4. Jereb B, Bretsky SS, Vogel R, et al. Age and prognosis in neuroblastoma. Review of 112 patients younger than 2 years. Am J Pediatr Hematol Oncol 1984; 6: 233-243.
5. Schmidt ML, Lukens JN, Seeger RC, et al. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol 2000; 18: 1260-1268.
6. Schmidt ML, Lal A, Seeger RC, et al. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: A Children's Cancer Group Study. J Clin Oncol 2005; 23: 6474-6480.
7. George RE, London WB, Cohn SL, et al. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 2005; 23: 6466-6473.
8. Evans AE, D'Angio GJ, Randolph J. A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer 1971; 27: 374-378.
9. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11: 1466-1477.
10. Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study. J Clin Oncol 2000; 18: 477-486.
11. Katzenstein HM, Bowman LC, Brodeur GM, et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: The pediatric oncology group experience-A pediatric oncology group study. J Clin Oncol 1998; 16: 2007-2017.
12. Baker DL, Schmidt ML, Cohn SL, et al. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med 2010; 363: 1313-1323.
13. van Noesel MM, Hahlen K, Hakvoort-Cammel FG, et al. Neuroblastoma 4S: A heterogeneous disease with variable risk factors and treatment strategies. Cancer 1997; 80: 834-843.
14. Martinez DA, King DR, Ginn-Pease ME, et al. Resection of the primary tumor is appropriate for children with stage IV-S neuroblastoma: An analysis of 37 patients. J Pediatr Surg 1992; 27: 1016-1020; discussion 1020-1021.
15. Yule SM, Anderson J. Hepatic cirrhosis and portal hypertension in neuroblastoma. Pediatr Hematol Oncol 2000; 17: 457-461.
16. Hsu LL, Evans AE, D'Angio GJ. Hepatomegaly in neuroblastoma stage 4s: Criteria for treatment of the vulnerable neonate. Med Pediatr Oncol 1996; 27: 521-528.
17. Schleiermacher G, Rubie H, Hartmann O, et al. Treatment of stage 4s neuroblastoma-Report of 10 years' experience of the French Society of Paediatric Oncology (SFOP). Br J Cancer 2003; 89: 470-476.
18. Paulino AC, Mayr NA, Simon JH, et al. Locoregional control in infants with neuroblastoma: Role of radiation therapy and late toxicity. Int J Radiat Oncol Biol Phys 2002; 52: 1025-1031.
19. Levitt GA, Platt KA, De Byrne R, et al. 4S neuroblastoma: The long-term outcome. Pediatr Blood Cancer 2004; 43: 120-125.
20. Laverdiere C, Cheung NK, Kushner BH, et al. Long-term complications in survivors of advanced stage neuroblastoma. Pediatr Blood Cancer 2005; 45: 324-332.
21. Escobar MA, Grosfeld JL, Powell RL, et al. Long-term outcomes in patients with stage IV neuroblastoma. J Pediatr Surg 2006; 41: 377-381.
22. Laverdiere C, Liu Q, Yasui Y, et al. Long-term outcomes in survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2009; 101: 1131-1140.
23. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109-122.
24. Furuse J, Ishii H, Nagase M, et al. Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2005; 20: 1512-1518.
25. Mahmoud H, Schell M, Pui CH. Cholelithiasis after treatment for childhood cancer. Cancer 1991; 67: 1439-1442.
26. Lawrence TS, Robertson JM, Anscher MS, et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995; 31: 1237-1248.
27. Choi BY, Nguyen MH. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 2005; 39: 401-412.
28. Bouyn CI, Leclere J, Raimondo G, et al. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 2003; 97: 3107-3113.
29. Joyner BL, Jr., Levin TL, Goyal RK, et al. Focal nodular hyperplasia of the liver: A sequela of tumor therapy. Pediatr Radiol 2005; 35: 1234-1239.
30. Marabelle A, Campagne D, Dechelotte P, et al. Focal nodular hyperplasia of the liver in patients previously treated for pediatric neoplastic diseases. J Pediatr Hematol Oncol 2008; 30: 546-549.
31. Benz-Bohm G, Hero B, Gossmann A, et al. Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma: How much diagnostic imaging is necessary? Eur J Radiol 2010; 74: e1-e5.
32. Gobbi D, Dall Igna P, Messina C, et al. Brief report: Focal nodular hyperplasia in pediatric patients with and without oncologic history. Pediatr Blood Cancer 2010; 55: 1420-1422.
33. Do RKG, Shaylor SD, Shia J, et al. Variable MR imaging appearances of focal nodular hyperplasia in pediatric cancer patients. Pediatr Radiol 2010; Dec 18 [Epub ahead of print].
34. Franken EA, Jr., Smith WL, Cohen MD, et al. Hepatic imaging in stage IV-S neuroblastoma. Pediatr Radiol 1986; 16: 107-109.
35. Children's Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers, Version 3.0. October 2008.